Trial intelligence / Profile preview

Regulation of colloid osmotic pressure during cardiopulmonary bypass in infants

2008-000069-41Phase 4Active

Sponsor
Erasmus MC
Start
Jan 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of albumin (human) in Cardiovascular Malformation (CVM) (2 arms), sponsored by Erasmus MC. Primary endpoints: Postoperative hematocrit level and Postoperative platelet count. Started Jan 2008; status: active.

02

Drugs

albumin (human)
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on 2008-000069-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-000069-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call